Comparison of Resolute Zotarolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients With De Novo Long Coronary Artery Lesions A Randomized LONG-DES IV Trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn, Jung-Min | - |
dc.contributor.author | Park, Duk-Woo | - |
dc.contributor.author | Kim, Young-Hak | - |
dc.contributor.author | Song, HaeGeun | - |
dc.contributor.author | Cho, Young-Rak | - |
dc.contributor.author | Kim, Won-Jang | - |
dc.contributor.author | Lee, Jong-Young | - |
dc.contributor.author | Kang, Soo-Jin | - |
dc.contributor.author | Lee, Seung-Whan | - |
dc.contributor.author | Lee, Cheol Whan | - |
dc.contributor.author | Park, Seong-Wook | - |
dc.contributor.author | Yun, Sung-Cheol | - |
dc.contributor.author | Han, Seungbong | - |
dc.contributor.author | Lee, Sung Yun | - |
dc.contributor.author | Lee, Bong-Ki | - |
dc.contributor.author | Cho, Jang-Hyun | - |
dc.contributor.author | Yang, Tae-Hyun | - |
dc.contributor.author | Lee, Nae-Hee | - |
dc.contributor.author | Yang, Joo-Young | - |
dc.contributor.author | Park, Jong-Seon | - |
dc.contributor.author | Shin, Won-Yong | - |
dc.contributor.author | Kim, Moo Hyun | - |
dc.contributor.author | Bae, Jang Ho | - |
dc.contributor.author | Kim, Myeong-Kon | - |
dc.contributor.author | Yoon, Junghan | - |
dc.contributor.author | Park, Seung-Jung | - |
dc.date.accessioned | 2021-08-12T02:45:17Z | - |
dc.date.available | 2021-08-12T02:45:17Z | - |
dc.date.issued | 2012-10 | - |
dc.identifier.issn | 1941-7640 | - |
dc.identifier.issn | 1941-7632 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/14824 | - |
dc.description.abstract | Background-Procedural and clinical outcomes still remain unfavorable for patients with long coronary lesions who undergo stent-based coronary interventions. Therefore, we compared the relative efficacy and safety of resolute zotarolimus-eluting stents (R-ZES) and sirolimus-eluting stents (SES) for patients with de novo long coronary lesions. Methods and Results-This randomized, multicenter, prospective trial, called the Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-IV (LONG-DES IV) trial, compared long R-ZES and SES in 500 patients with long (>= 25 mm) native coronary lesions. The primary end point of the trial was in-segment late luminal loss at 9-month angiographic follow-up. The baseline characteristics were not different between R-ZES and SES groups, including lesion lengths (32.4 +/- 13.5 mm versus 31.0 +/- 13.5 mm, P=0.27). At 9-month angiographic follow-up, the R-ZES was noninferior to the SES with respect to in-segment late luminal loss, the primary study end point (0.14 +/- 0.38 mm versus 0.12 +/- 0.43 mm, P for noninferiority=0.03, P for superiority=0.68). In addition, in-stent late luminal loss (0.26 +/- 0.36 mm versus 0.24 +/- 0.42 mm, P=0.78) and the rates of in-segment (5.2% versus 7.2%, P=0.44) and in-stent (4.0% versus 6.0%, P=0.41) binary restenosis were not significantly different between the 2 groups. There were no significant between-group differences in the rate of adverse clinical events (death, myocardial infarction, stent thrombosis, target-lesion revascularization, and composite outcomes). Conclusions-For patients with de novo long coronary artery disease, R-ZES implantation showed noninferior angiographic outcomes as compared with SES implantation. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Lippincott Williams & Wilkins Ltd. | - |
dc.title | Comparison of Resolute Zotarolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients With De Novo Long Coronary Artery Lesions A Randomized LONG-DES IV Trial | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1161/CIRCINTERVENTIONS.111.965673 | - |
dc.identifier.scopusid | 2-s2.0-84868641244 | - |
dc.identifier.wosid | 000313575800009 | - |
dc.identifier.bibliographicCitation | Circulation: Cardiovascular Interventions, v.5, no.5, pp 633 - 640 | - |
dc.citation.title | Circulation: Cardiovascular Interventions | - |
dc.citation.volume | 5 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 633 | - |
dc.citation.endPage | 640 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | IMPLANTATION | - |
dc.subject.keywordPlus | RESTENOSIS | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | SYSTEM | - |
dc.subject.keywordPlus | REVASCULARIZATION | - |
dc.subject.keywordPlus | INTERVENTION | - |
dc.subject.keywordPlus | THROMBOSIS | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordAuthor | angioplasty | - |
dc.subject.keywordAuthor | coronary disease | - |
dc.subject.keywordAuthor | stents | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.